The Knowledge Society (TKS) Dubai Edition is Now Accepting Applications for September 2025 Cohort – Apply by July 31, 2025
You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.
Dubai Future Foundation and The Knowledge Society (TKS) are now accepting applications for you TKS Dubai, an innovation program designed to equip high-potential students (ages 13–17) with the skills, knowledge, and mindset needed to thrive in a rapidly evolving world.
The Knowledge Society (TKS) – Dubai Edition is a 10-month innovation program that focuses on emerging fields like AI, biotechnology, space, nanotechnology, and more.
It provides cutting-edge knowledge in fields such as artificial intelligence, robotics, and biotechnology — all while connecting students to a global network of mentors, industry leaders, and future-focused thinkers.
In partnership with Dubai Future Foundation, TKS offers up to 30 full scholarships for UAE nationals and merit/need‑based aid for others.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures rise as earnings flood in, jobs data on deck
US stock futures moved higher on Tuesday, eyeing a bid for more records as investors combed through a fresh rush of corporate earnings and waited for key economic data in a big week on Wall Street. S&P 500 futures (ES=F) rose 0.3% on the heels of narrowly notching a sixth all-time closing high in a row. Dow Jones Industrial Average futures (YM=F) also edged up 0.2%, while contracts on the tech-heavy Nasdaq 100 (NQ=F) led the way higher with a 0.5% gain. The mood is modestly upbeat as a blockbuster week for markets gets into full swing. The Federal Reserve kicks off its two-day policy meeting on Tuesday, while the JOLTS job openings update for June due later ushers in a series of crucial labor data culminating in Friday's nonfarm payrolls report. Meanwhile, earnings take center stage as before-the-bell reports from Spotify (SPOT) and UnitedHealth (UNH) disappointed Wall Street. Results from Boeing (BA) and Starbucks (SBUX) will be scrutinized for signs of turnaround progress and of the impact of tariffs on outlooks. That sets the tone for this week's highlights, results from tech giants Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). Read more: Full earnings coverage in our live blog Also looming large is President Trump's deadline Friday for trading partners to strike deals or face blanket tariff rates. Hopes for an extension to the US-China trade truce are buoying the likes of AI chipmaker Nvidia's (NVDA) stock. Read more: The latest on Trump's tariffs Trade war fears may have lost their grip on markets, given the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) only barely managed new records on Monday despite a new US-EU trade deal. On Tuesday's economic docket, Conference Board's July reading on consumer confidence and a S&P CoreLogic print on home prices in May provide a health check on the economy ahead of an update on second quarter GDP later this week, Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
14 minutes ago
- Business Wire
Viz.ai Announces CMS Reimbursement Pathway for Hypertrophic Cardiomyopathy via AI-Enhanced Electrocardiogram
SAN FRANCISCO--(BUSINESS WIRE)-- the leader in AI-powered disease detection and intelligent care coordination, today announced that the Category III CPT codes for AI-enabled electrocardiogram (ECG) analysis accepted and established by the American Medical Association (AMA) CPT Editorial Panel establish a national reimbursement framework for AI algorithms that perform ECG analysis for cardiac pathology, including conditions like hypertrophic cardiomyopathy (HCM), for which Viz HCM was designed. The Centers for Medicare & Medicaid Services established a Medicare rate of $128.90, effective January 1, 2025, for CPT codes 0764T and 0765T which apply to 'electrocardiograph, computerized analysis with artificial intelligence, for detection of cardiac pathology, with physician or other qualified health care professional interpretation and report' related to concurrently performed ECG or previously performed ECG respectively. These codes facilitate national reimbursement for AI algorithms like Viz HCM, which analyzes 12-lead ECGs to identify patterns consistent with HCM, a condition that often goes undiagnosed until serious complications arise. 'This is a major milestone for AI in cardiovascular care,' said Jamie Stern, senior director of Care Pathways at 'Reimbursement for AI-powered ECG interpretation empowers clinicians to identify high-risk patients earlier, before symptoms progress or serious events occur—supporting more timely diagnosis, specialist referral, and treatment.' Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death, particularly in younger adults. Yet the majority of individuals living with HCM are undiagnosed. Viz HCM uses deep learning to flag patients at risk based on ECG data captured across a healthcare system in routine clinical workflows, advancing early detection and closing critical gaps in care. A recent study, published in JACC: Clinical Electrophysiology, demonstrated that Viz HCM achieved a high degree of accuracy in detecting HCM 1. The AI-ECG successfully identified 574 HCM patients, and in 691 cases where HCM was not identified the AI-ECG assisted in identifying alternate clinically relevant diagnosis, highlighting Viz HCM's value for more effective disease detection. "Reimbursement is a meaningful step forward for the uptake of novel technologies,' said Joshua M. Lampert, MD, FACC, cardiac electrophysiologist and medical director of Machine Learning at Mount Sinai Fuster Heart Hospital. 'This development can provide institutions with a sustainable means to build and maintain the necessary infrastructure to provide safe and effective care for patients during an actively evolving healthcare modernization process." The CPT codes 0764T and 0765T were first published in the CPT 2023 code set, effective for use on or after January 1, 2023. However, CMS had not established a national payment for these codes until January 1, 2025. This development enables physicians and health systems to integrate reimbursable AI-based ECG interpretation into routine care delivery. Viz HCM is part of the One Platform, which connects disparate data and care teams in real time to accelerate diagnosis, streamline care coordination, and improve outcomes across a range of cardiovascular and neurological conditions. 1 Desai, M. Y., Rutkowski, K., Ospina, S., et al. (2025). Real‑world artificial intelligence–based electrocardiographic analysis to diagnose hypertrophic cardiomyopathy. JACC: Clinical Electrophysiology, 11(6). About is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,800 hospitals and health systems in the U.S. and Europe. The AI-powered One® is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit
The Verge
16 minutes ago
- The Verge
Trump's AI plan is a massive handout to gas and chemical companies
The Trump administration put out its vision for AI infrastructure in the US last week. It's a dream for the fossil fuel and chemical industries — and a nightmare for wind and solar energy and the environment. An 'AI Action Plan' and flurry of executive orders Donald Trump signed last week read like manifestos on making AI less 'woke' and less regulated. They're packed with head-spinning proposals to erode bedrock environmental protections in the US, on top of incentives for companies to build out new data centers, power plants, pipelines, and computer chip factories as fast as they can. It's a deregulation spree and a massive handout to fossil fuels, all in the name of AI. What the AI plan 'is really about' is 'using unprecedented emergency powers to grant massive new exemptions for data centers and specifically fossil fuel infrastructure,' says Tyson Slocum, energy program director at the consumer advocacy group Public Citizen. 'I think they have a genuine interest in accommodating Big Tech's priorities. But it's an opportunity to marry their priorities for Big Oil.' 'It's an opportunity to marry their priorities for Big Oil.' Data centers are notoriously energy-hungry and have already led to a surge of new gas projects meant to satiate rising demand. But many tech companies have sustainability commitments they've pledged to meet using renewable energy, and as wind and solar farms have generally grown cheaper and easier to build than fossil fuel power plants, they've become the fastest-growing sources of new electricity in the US. Now, Trump wants to turn that on its head. He signed an executive order on July 23rd meant to 'accelerat[e] federal permitting of data center infrastructure.' It tells the Secretary of Commerce to 'launch an initiative to provide financial support' for data centers and related infrastructure projects. That could include loans, grants, and tax incentives for energy infrastructure — but not for solar and wind power. The executive order describes 'covered components' as 'natural gas turbines, coal power equipment, nuclear power equipment, geothermal power equipment' and any other electricity sources considered 'dispatchable.' To be considered dispatchable, operators have to be able to ramp electricity generation up and down at will, so this excludes intermittent renewables like solar and wind power that naturally fluctuate with the weather and time of day. Trump's AI planning document similarly says the administration will prioritize deploying dispatchable power sources and that 'we will continue to reject radical climate dogma.' Already, Trump has dealt killer blows to solar and wind projects by hiking up tariffs and cutting Biden-era tax credits for renewables. The AI executive order goes even further to entrench reliance on fossil fuels and make it harder for new data centers to run on solar and wind energy. 'Right now, you do not qualify for expedited treatment if your data center proposal has wind and solar. It is excluded from favorable treatment,' Slocum says. 'So what's the statement for the market? Don't rely on wind and solar.' That's not just environmentally unfriendly, it's inefficient — considering the current backlog for gas turbines and because fossil fuel plants are generally slower and more expensive to build than onshore wind and solar farms. 'This is not an energy abundance agenda. This is an energy idiot agenda,' Slocum adds. The Trump administration wants to speed things up by rewriting bedrock environmental laws. Trump, ever the disgruntled real estate mogul, has railed against environmental reviews he says take too long and cost too much. He has already worked to roll back dozens of environmental regulations since stepping into office. Now, the executive order directs the Environmental Protection Agency (EPA) to modify rules under the Clean Air Act, Clean Water Act, Superfund law, and Toxic Substances Control Act to expedite permitting for data center projects. 'That is horrifying … These [laws] protect our public health. They protect our children. They protect the air we breathe and the water we drink,' says Judith Barish, coalition director of CHIPS Communities United, a national coalition that includes labor and environmental groups. 'This is an energy idiot agenda.' The coalition has come together to fight for protections for workers in the chip industry and nearby communities. Semiconductor manufacturing has a long history of leaching harmful chemicals and exposing employees to reproductive health toxins. Santa Clara, California, home of Silicon Valley, has more toxic Superfund sites than any other county in the US as a result. The coalition wants to keep history from repeating itself as the US tries to revive domestic chip manufacturing and dominate the AI market. AI requires more powerful chips, and Trump's executive order fast-tracking federal permitting for data center projects includes semiconductors and 'semiconductor materials.' Barish says 'a chip factory is a chemical factory' because of all the industrial solvents and other chemicals semiconductor manufacturers use. That includes 'forever chemicals,' for which the Trump administration has started to loosen regulations on how much is allowed in drinking water. Companies including 3M and Dupont have faced a landslide of lawsuits over forever chemicals linked to cancer, reproductive risks, liver damage, and other health issues, and have subsequently made pledges to phase out or phase down the chemicals. Now, manufacturers are jumping on the opportunity to produce more forever chemicals to feed the AI craze. Ironically, we could see data centers and related infrastructure popping up on polluted Superfund sites that Silicon Valley has already left in its tracks. Trump's executive order directs the EPA to identify polluted Superfund and Brownfield sites that could be reused for new data center projects (and tells other agencies to scour military sites and federal lands for suitable locations). Office buildings are already situated on or adjacent to old Superfund sites where cleanup is ongoing; Google workers were exposed to toxic vapors rising from a Superfund site below their office back in 2013. Since it can take decades to fully remediate a site, oversight is key. 'For Superfund sites in particular, these are the most contaminated sites in the country, and it is important that there are comprehensive reviews both for the people who are going to be working on the sites, as well as for the people who surround them,' says Jennifer Liss Ohayon, a research scientist at the Silent Spring Institute who has studied the remediation of Superfund sites. But Trump wants to erode oversight for new data center projects that receive federal support — adding 'categorical exclusions' to typical National Environmental Policy Act assessments. Environmental reviews that do take place could also be limited by the sheer lack of people power at federal agencies the Trump administration has hacked to pieces, including the EPA. 'America needs new data centers, new semiconductor and chip manufacturing facilities, new power plants and transmission lines,' Trump said before signing his AI executive orders last week. 'Under my leadership we're going to get that job done and it's going to be done with certainty and with environmental protection and all of the things we have to do to get it done properly.' Good luck. Posts from this author will be added to your daily email digest and your homepage feed. See All by Justine Calma Posts from this topic will be added to your daily email digest and your homepage feed. See All AI Posts from this topic will be added to your daily email digest and your homepage feed. See All Analysis Posts from this topic will be added to your daily email digest and your homepage feed. See All Climate Posts from this topic will be added to your daily email digest and your homepage feed. See All Environment Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy Posts from this topic will be added to your daily email digest and your homepage feed. See All Politics Posts from this topic will be added to your daily email digest and your homepage feed. See All Regulation Posts from this topic will be added to your daily email digest and your homepage feed. See All Science
